The Lancet Oncology: Young cancer survivors face higher risk of severe health problems in later life than the general population, study suggests

February 14, 2020

Cancer survivors who are diagnosed during adolescence or early adulthood (age 15-20 years) are at increased risk of premature death compared to the general population. They have an elevated risk of severe or life-threatening conditions compared to a sibling control group, according to an observational study of more than 10,000 cancer patients from 27 academic institutions in the USA and Canada, published in The Lancet Oncology journal on International Childhood Cancer Day (15 February).

The study involved people diagnosed with cancer between 1970 and 1999, so it is not clear whether young adults diagnosed today can expect similar outcomes as treatments have improved in the intervening decades. Nevertheless, the authors say their findings highlight the need for long-term screening of young cancer survivors throughout their lives.

Childhood cancer survivors are known to have a higher risk of early death and long-term health problems related to their treatment, including heart conditions and circulatory problems. Little is known about the long-term consequences of cancer treatment on adolescents and young adults, however.

Dr Eugene Suh, Loyola University Chicago Health Sciences, USA, explains: "While previous studies have examined long-term outcomes for people who survive five years or more after cancer diagnosis in childhood or adulthood, our study is the first to specifically investigate health consequences for those diagnosed in adolescence and young adulthood. These survivors have the potential to live long, healthy lives but they remain at risk of health problems as a consequence of their previous cancer treatments." [1]

In the new study, the researchers examined data from the Childhood Cancer Survivor Study, which has been tracking health outcomes from more than 24,000 people who were diagnosed between 1970 and 1999 in the USA and survived for five or more years after diagnosis.

The team focused on study participants who were aged between 15 and 21 years at the time of their initial cancer diagnosis (5,804 people). For comparison, the team randomly selected a cohort of childhood cancer survivors diagnosed with the same cancers before age 15 from the larger study database (5,804 people). A third group of siblings of similar ages was also recruited for comparison (5,059).

The researchers tracked the death rates and causes of death for each group. They also examined medical records for occurrences of cancer, severe health problems associated with the heart, lungs, and musculoskeletal systems, as well as metabolic and neurological conditions. These are common consequences of cancer treatments such as radiotherapy and chemotherapy.

Based on their analysis, the authors estimate that the likelihood of a young adult cancer survivor developing a severe health condition by age 45 was 39% (one in 2.6), compared with 12% for siblings of the same age (one in 8). The risks for people diagnosed as adolescents were lower than those of childhood cancer survivors diagnosed before age 15, where the likelihood of developing a severe condition by age 45 was 56% (more than one in two).

The risk of mortality from any cause among young adult survivors was almost six times higher than would be expected in those of same age and sex in the general population (standardized mortality ratio [SMR] 5.9, 1357 deaths compared with an expected 231.9). The standardized mortality ratio for childhood cancer survivors was similarly elevated over the general population (SMR 6.2, 963 deaths compared with an expected 155.7).

Early adolescent and young adult survivors were 1.6 times as likely to die from recurrence or progression of their primary cancer compared with childhood cancer survivors (492 deaths of adolescent survivors compared with 325 deaths of childhood survivors).

The differences in health outcomes between childhood survivors and young adults were most notable twenty years after diagnosis. The researchers say this underlines the importance of long-term health screening for both groups of cancer survivors.

Dr Tara Henderson, Associate Professor at the University of Chicago, USA, said: "Focused efforts are needed to ensure young adult cancer survivors receive long-term health monitoring, with a focus on cancer screening, to reduce their risk of health problems and early death. Studies have shown that adherence to such programmes is poor, so we need to do more to highlight the importance of lifelong care to survivors and their families, as well as primary health care providers. We also need further research to understand how best to deliver risk-based care for survivors that incorporates both cancer specialists and primary care providers in the community." [1]

The researchers caution that their findings may not be generalisable to patients treated today, who are likely to receive different treatment regimens than in previous decades.

An additional limitation is that the cohort of survivors included in the study did not include the full range of cancers typically seen in this age group. Notably, those with gonadal tumours, melanomas and thyroid cancers were not included, yet these account for almost 40% of cancers diagnosed between the ages of 15 and 20 years.

Writing in a linked Comment, Dr Paivi Lahteenmaki (who was not involved in the study), Turku University, Finland, said: "Accurately characterising individuals at high risk who would benefit from a tailored screening programme is most important. In the future, identifying underlying genetic or molecular factors that might define patients at high risk of late sequelae would help planning approaches to survivorship."
-end-
NOTES TO EDITORS

This study was funded by the US National Institute of Health, a Cancer Centre Support (CORE) Grant to St Jude Children's Research Hospital and the American Lebanese Syrian Associated Charities. It was conducted by researchers from Loyola University Chicago Health Sciences, Fred Hutchinson Cancer Research Center, The University of Toronto, City University of New York, Children's Hospital Los Angeles, University of Chicago, The University of Texas MD Anderson Cancer Center, St Jude Children's Research Hospital, Memorial Sloan Kettering Cancer Center, University of Minnesota and Duke University School of Medicine.

The labels have been added to this press release as part of a project run by the Academy of Medical Sciences seeking to improve the communication of evidence. For more information, please see: http://www.sciencemediacentre.org/wp-content/uploads/2018/01/AMS-press-release-labelling-system-GUIDANCE.pdf if you have any questions or feedback, please contact The Lancet press office pressoffice@lancet.com

[1] Quote direct from author and cannot be found in the text of the Article.

Peer reviewed / Observational study / People

The Lancet

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.